Mark T. Houser - Net Worth and Insider Trading

Mark T. Houser Net Worth

The estimated net worth of Mark T. Houser is at least $124,098 dollars as of 2024-11-13. Mark T. Houser is the Chief Medical Officer of Cormedix Inc and owns about 10,566 shares of Cormedix Inc (CRMD) stock worth over $124,098. Details can be seen in Mark T. Houser's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark T. Houser has not made any transactions after 2010-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark T. Houser

To

Mark T. Houser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark T. Houser owns 1 companies in total, including Cormedix Inc (CRMD) .

Click here to see the complete history of Mark T. Houser’s form 4 insider trades.

Insider Ownership Summary of Mark T. Houser

Ticker Comapny Transaction Date Type of Owner
CRMD Cormedix Inc 2010-11-26 Chief Medical Officer

Mark T. Houser Latest Holdings Summary

Mark T. Houser currently owns a total of 1 stock. Mark T. Houser owns 10,566 shares of Cormedix Inc (CRMD) as of November 26, 2010, with a value of $124,098.

Latest Holdings of Mark T. Houser

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRMD Cormedix Inc 2010-11-26 10,566 11.75 124,098

Holding Weightings of Mark T. Houser


Mark T. Houser Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark T. Houser has made a total of 0 transactions in Cormedix Inc (CRMD) over the past 5 years. The most-recent trade in Cormedix Inc is the acquisition of 1,000 shares on November 26, 2010, which cost Mark T. Houser around $6,500.

Insider Trading History of Mark T. Houser

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark T. Houser Trading Performance

GuruFocus tracks the stock performance after each of Mark T. Houser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark T. Houser is 11.99%. GuruFocus also compares Mark T. Houser's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark T. Houser within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark T. Houser's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark T. Houser

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.95 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 22.02 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark T. Houser Ownership Network

Ownership Network List of Mark T. Houser

No Data

Ownership Network Relation of Mark T. Houser

Insider Network Chart

Mark T. Houser Owned Company Details

What does Cormedix Inc do?

Who are the key executives at Cormedix Inc?

Mark T. Houser is the Chief Medical Officer of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Chief Financial Officer Matthew T David .

Cormedix Inc (CRMD) Insider Trades Summary

Over the past 18 months, Mark T. Houser made no insider transaction in Cormedix Inc (CRMD). Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 28,561 shares made by Joseph Todisco , a net purchase of 9,000 shares made by Alan W Dunton , and a net purchase of 10,000 shares made by Paulo F Costa .

In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 64,561 shares were bought by its insiders, resulting in a net purchase of 64,561 shares.

Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cormedix Inc Insider Transactions

No Available Data

Mark T. Houser Mailing Address

Above is the net worth, insider trading, and ownership report for Mark T. Houser. You might contact Mark T. Houser via mailing address: C/o Cormedix Inc., 86 Summit Avenue, Suite 301, Summit Nj 07901-3647.